Safety of Insertion of Percutaneous Totally Implantable Central Venous Access Devices by Surgical Residents

xlomafota13 shared this article with you from Inoreader Safety of Insertion of Percutaneous Totally Implantable Central Venous Access Devices by Surgical Residents Via In vivo (Athens, Greece) In Vivo. 2022 Mar-Apr;36(2):985-993. doi: 10.21873/invivo.12791. ABSTRACT BACKGROUND/AIM: To compare the outcomes of totally implantable central venous access device (TIVAD) insertions by surgical residents (SRs) with those by experienced surgeons (ESs) and establish the safety of percutaneous TIVAD insertion by SRs. PATIENTS AND METHODS: A total of 700 insertions were successfully performed between January 2015 and December 2019 in our Department. The puncture site conversion and complication rates were compared, and risk factors related to complications were analysed. RESULTS: In total, 84 and 616 insertions were performed in the SR and ES groups, respectively. SRs mainly punctured the internal jugular vein (IJV), and ESs punctured the subclavian vein (SV). The conversion rate from the IJV to SV was similar, whereas that from the SV to IJV was higher by SRs than ESs. Overall, early, and delayed complications were similar between the two groups. CONCLUSION: Percutaneous TIVAD inserted into the IJV by an SR was demonstrated to be safe. PMID:35241560 | DOI:10.21873/invivo.12791 View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.